These aren't the glory days for med-tech giant Medtronic (NYSE:MDT), as fiscal 2014 will be a pretty weak year from a growth perspective ahead of some significant new product launches in 2015. Even with a high-quality name like Medtronic, that lack of growth can lead to shares languishing as investors are attracted to (or distracted by) more impressive-looking stories in the short term. Although I'm not a passionate bull on Medtronic shares by any stretch, the stock is pretty much what passes for a bargain these days in the larger segment of this industry and I think it's a respectable core holding.
Please follow the link to continue:
http://www.investopedia.com/stock-analysis/082013/medtronic-marking-time-mdt-stj-bsx-jnj.aspx
Investopedia: Medtronic Marking Time
0 comments:
Post a Comment